CVS Health Appoints Dr. Sreekanth Chaguturu as President of Health Care Delivery
CVS Health® (NYSE: CVS) has announced that Dr. Sreekanth Chaguturu, currently serving as executive vice president and chief medical officer of CVS Health, will take on an expanded role as president of Health Care Delivery. Dr. Chaguturu succeeds Mike Pykosz,…
Gilead Sciences Awards $1 Million Grant to The Children’s Inn at NIH
The Children’s Inn at the National Institutes of Health (NIH) has announced that Gilead Sciences Inc. has awarded a $1 million grant to support its ongoing renovation and expansion efforts. This funding will specifically be used to create a welcome…
BioFuture™ 2024 Concludes with Record Investor and Media Attendance
The BioFuture™ 2024 conference, organized by Demy-Colton, concluded in New York and virtually, marking the largest turnout in the event’s history. This year’s conference brought together more than 100 speakers, over 100 investors, 62 presenting companies, and 48 journalists, all…
OverT Bio Wins $120K G-Rex® Grant for Solid Tumor Cell Therapy
OverT Bio, a cell therapy company based in New York City, has announced it has received a $120,000 G-Rex Grant from ScaleReady™, in partnership with Wilson Wolf Manufacturing, Bio-Techne Corporation (NASDAQ: TECH), and CellReady™. The grant will support OverT Bio’s…
GE HealthCare Unveils Advanced Imaging for OEC 3D C-arm to Enhance Precision in Interventional Pulmonology
GE HealthCare (Nasdaq: GEHC) has introduced new clinical applications to its OEC 3D mobile CBCT C-arm portfolio, designed to enhance precise and efficient imaging during endoscopic bronchoscopy procedures in interventional pulmonology. Complex pulmonary and thoracic procedures require precise intraoperative imaging…
Pulmonary Hypertension Awareness Month: Two European Studies Urge Better Diagnosis and Treatment
During Pulmonary Hypertension Awareness Month, two European studies emphasize the urgent need for improved diagnosis and treatment of pulmonary hypertension linked to interstitial lung disease. Pulmonary Hypertension (PH) is a condition characterized by high blood pressure in the pulmonary arteries,…
Rigaku Opens New Bioscience Lab in the U.S.
Rigaku Corporation, a global leader in X-ray analytical equipment and a member of the Rigaku Holdings Group, has officially opened the Rigaku Bioscience Laboratory in Cambridge, Massachusetts. Rigaku Corporation has begun operating its MoleQlyze technology at the newly opened Rigaku…
Exai Bio Publishes in Nature Communications on AI Liquid Biopsy Platform
Exai Bio, a next-generation company specializing in oncRNA and generative AI-based liquid biopsy technologies, has announced the publication of a peer-reviewed paper in Nature Communications. The study, titled “Deep generative AI models analyzing circulating orphan non-coding RNAs enable detection of…
Greenspace Health Named to 2024 Deloitte Technology Fast 500™
Greenspace Health, a leading provider of Measurement-Based Care (MBC) technology for behavioral health services, has been named to the 2024 Deloitte Technology Fast 500™. This prestigious ranking highlights the 500 fastest-growing companies in North America across technology, media, telecommunications, life…
Aptar Digital Health Partners with University of Geneva on Migraine Research
Aptar Digital Health, a global leader in digital health solutions, has announced a partnership with the Quality of Life (QoL) technologies lab at the University of Geneva, Switzerland, to enhance migraine research. The collaboration aims to improve the understanding of…
Nym Recognized in Healthcare Technology Report’s Top 100 Companies
Nym, a leader in autonomous medical coding, has been recognized in The Healthcare Technology Report’s list of Top 100 Healthcare Technology Companies for 2024. This accolade highlights Nym’s significant contribution to automating and streamlining revenue cycle management for healthcare providers,…
Alloy Therapeutics Partners with Takeda to Develop Cell Therapy Platform
Alloy Therapeutics Inc., a biotechnology ecosystem company focused on democratizing access to advanced drug discovery technologies, has announced a strategic collaboration and licensing agreement with Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK). The partnership will aim to develop Takeda’s proprietary induced pluripotent…